Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VELAGLUCERASE ALFA Cause Product prescribing issue? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product prescribing issue have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 0.4% of all adverse event reports for VELAGLUCERASE ALFA.

7
Reports of Product prescribing issue with VELAGLUCERASE ALFA
0.4%
of all VELAGLUCERASE ALFA reports
1
Deaths
2
Hospitalizations

How Dangerous Is Product prescribing issue From VELAGLUCERASE ALFA?

Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does VELAGLUCERASE ALFA Cause?

Inappropriate schedule of product administration (197) Product dose omission issue (188) Covid-19 (163) Fatigue (136) Death (108) Fall (104) Pyrexia (101) Malaise (98) Weight increased (89) Headache (88)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which VELAGLUCERASE ALFA Alternatives Have Lower Product prescribing issue Risk?

VELAGLUCERASE ALFA vs VELCADE VELAGLUCERASE ALFA vs VELETRI VELAGLUCERASE ALFA vs VELIPARIB VELAGLUCERASE ALFA vs VEMURAFENIB VELAGLUCERASE ALFA vs VENETOCLAX

Related Pages

VELAGLUCERASE ALFA Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue VELAGLUCERASE ALFA Demographics